Oncology Institute (TOIIW) Other Non-Current Liabilities (2021 - 2026)

Oncology Institute has reported Other Non-Current Liabilities for 6 years, with the latest figure at $19000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 83.76% year-over-year to $19000.0; the trailing twelve-month figure through Mar 2026 stood at $19000.0 (down 83.76% YoY), and the FY2025 full-year result was $28000.0, down 92.73% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $19000.0, down from $28000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $13.7 million in Q3 2025, with the low at $19000.0 in Q1 2026.
• Historically, Other Non-Current Liabilities has averaged $2.9 million across 5 years, with a median of $514000.0 in 2024.
• Annual changes were most pronounced in 2023 — Other Non-Current Liabilities slumped 96.37% — and 2025, when it soared 2557.2%.
• Oncology Institute's Other Non-Current Liabilities stood at $4.0 million in 2022, then plunged by 90.78% to $365000.0 in 2023, then climbed by 5.48% to $385000.0 in 2024, then plunged by 92.73% to $28000.0 in 2025, then plunged by 32.14% to $19000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $19000.0 (Q1 2026), $28000.0 (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.